000100 — Yuhan Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapFalling Star

Market Cap
KR₩7tn
Enterprise Value
KR₩7tn
Revenue
KR₩2tn

Annual income statement for Yuhan, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,687,810	1,775,847	1,858,984	2,067,791	2,186,638
Cost of Revenue
Gross Profit	524,651	518,202	565,864	689,386	729,918
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,651,599	1,751,073	1,763,138	2,036,703	2,002,433
Operating Profit	36,211	24,774	95,846	31,088	184,205
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	126,061	94,926	134,813	61,432	222,675
Provision for Income Taxes
Net Income After Taxes	99,127	90,593	134,241	55,163	185,319
Minority Interest
Net Income Before Extraordinary Items
Net Income	102,583	95,144	136,198	70,687	194,079
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	100,849	93,678	134,101	69,593	191,087
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,423	1,410	1,291	1,164	1,695
Dividends per Share